Prognostic factors for breast cancer survival in affluent and deprived areas Jasmina Stefoski-Mikeljevic.

Slides:



Advertisements
Similar presentations
NORTH WESTERN CANCER REGISTRY BLADDER CANCER: Later stage and worse survival in women from deprived areas British Journal of Cancer (2004) 90,
Advertisements

Patient delay and associated factors in women with breast cancer Edita Bronė Juodžbalienė Edita Bronė JuodžbalienėKaunas EUROCHIP II actions and interventions.
March 2002 Outcomes in thyroid cancer: what factors are important? Information Projects Team Outcomes in thyroid cancer: what factors are important? NYCRIS.
Casulo C et al. Proc ASH 2013;Abstract 510.
The National Cancer Intelligence Network An overview Professor David Forman Professor of Cancer Epidemiology, University of Leeds NCIN – Lead for Information.
Is the rate of biological ageing, as measured by age at diagnosis of cancer, socio-economically patterned? Dr. Jean Adams School of Population and Health.
Impact of Cancer Diagnosis and Chemotherapy on Mammography Use Xinhua Yu, M.B., Ph.D. A. Marshall McBean, M.D., M.Sc. Beth A. Virnig, Ph.D., M.P.H Division.
By Rachel, Xiao Xia, Helen. Introduction Definition Symptoms Causes Prevention Treatment Prognosis Statistics Conclusion.
West Midlands Regional Genetics Laboratory
West Midlands Cancer Intelligence Unit NHSBSP Surgical QA Data for the Year of Screening 1 April 2002 to 31 March 2003 Dr Gill Lawrence and Professor Jan.
The All Breast Cancer Report was published in October breastscreen/research.html#breast- cancer-report.
Breast Cancer Screening Beyond 70 Years Old Henry Kwok Breast Imaging Fellow BreastScreen Aotearoa Counties Manukau.
Racial/Ethnic Disparities in Cancer Incidence, Survival and Treatment Linda C. Harlan, PhD, MPH National Cancer Institute Division of Cancer Control and.
Description of fracture with endocrine therapy use in older breast cancer survivors in a population-based setting Taryn Becker 123, Geoff Anderson 123,
FEMALE BREAST CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/03/20014.
1 Key concepts, data, methods and results Index Trends in cancer survival by ethnic and socioeconomic group, New Zealand, Soeberg M, Blakely.
Ethnic Disparities in Early Breast Cancer Management among Asian Americans and Pacific Islanders Rebecca P. Gelber, MD, MPH Department of Medicine, University.
Kathrin Strasser-Weippl 1 st Medical Department Wilhelminen Hospital, Vienna Cancer Care in Europe.
SOCIO-ECONOMIC STATUS AND MORTALITY FROM CARDIOVASCULAR DISEASE AMONG PEOPLE WITH TYPE 2 DIABETES IN SCOTLAND ( ) Caroline Jackson, Jeremy Walker,
THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/02/2013.
Breast Cancer Care of Mexican American Women in High Poverty California Neighborhoods: Protective Effects of Social and Financial Capital, Including Health.
PROSTATE CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/01/2013.
MELANOMA JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.
A Glimpse of the Science Behind the American Cancer Society Access to Care Campaign Impact of Being Uninsured or Underinsured on Individuals with Cancer.
SEER Provided Data Mohammad Afnan Baqai 12/3/2009.
North East Bowel Screening Cancer Study Doctorate of Medicine, University of Durham.
Socio-economic inequalities in the pathway of care for pancreatic cancer James Brown, Jean Adams, Martin White & Mark Pearce Institute of Health & Society.
May 2001 Management of Thyroid Cancer Information Projects Team THE MANAGEMENT OF PATIENTS WITH THYROID CANCER Cathy Bennett Information Projects Manager.
FC and FCR in CLL and Indolent NHL: A descriptive retrospective institutional study Aftimos P, Chahine G Hotel-Dieu de France University Hospital Beirut,
13 site specific articles 13 site specific articles Adult patients (age 15+) Adult patients (age 15+) Survival by subsite, tumour morphology, stage Survival.
Snyder D, Heidel RE, Panella T, Bell J, Orucevic A University of Tennessee Medical Center – Knoxville Departments of Pathology, Surgery, and Medicine BREAST.
THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.
Acknowledgements This report differs from the submitted abstract due to further subdivision of patients into analytic and non- analytic, and focus on the.
THE EFFECT OF AGE ON OUTCOME OF SYNOVIAL SARCOMA PATIENTS A DUTCH POPULATION BASED STUDY Myrella Vlenterie, SEJ Kaal, VKY Ho, R Vlenterie, WTA van der.
Failure to appropriately screen women according to international guidelines– what are the consequences? Alison Johnston*, M Sugrue, S Curran Department.
Urban/Rural Differences in Survival Among Medicare Beneficiaries with Breast Cancer Melony E.S. Sorbero, Ph.D. RAND Corporation Funded by Health Resources.
Incidence and prognosis of hepatocellular adenoma in Denmark Lars Bossen Departments of Hepatology and Gastroenterology and Clinical Epidemiology Aarhus.
Treatment Patterns in the Management of Prostate Cancer: Lessons Learned from the Florida Cancer Data System Vonetta L. Williams, PhD, MPH, CTR June 23,
Extranodal Extension on Sentinel Lymph Node Dissection: Why Should We Treat It Differently? Audrey Choi MD, Matthew Surrusco MD, Samuel Rodriguez MD, Khaled.
Kathleen Decker Alain Demers Daniel Chateau Marion Harrison Cervical Cancer in Manitoba: evaluating risk, Pap test utilization, and access CancerCare Manitoba.
Joanne Edwards Medical Information Manager ASCO Tech Assessment Update Commercial Implications & Promotional Guidance.
Cancer Committee Meeting May 11, 2015 Cancer Liaison Physician Report Karen Lisa Smith MD MPH.
National Cancer Intelligence Network Outcome and the effect of age in 1318 patients with synovial sarcoma: Report from the National Cancer Intelligence.
Using SEER-Medicare Data to Enhance Registry Data to Assess Quality of Care Joan Warren Applied Research Program National Cancer Institute NAACCR June.
Erlotinib Therapy in Non Small Cell Lung Cancer Patients - Survival of Patients on Reduced Erlotinib Doses M. Pesek 1, J. Krejci 1, J. Skrickova 2, P.
Two-week wait referrals for malignant melanoma: A clinical audit carried out across four UK Cancer Networks South West Cancer Intelligence Service
Routes to Diagnosis of Cancer in London, Katherine Henson, NCRAS, Presentation for London Public Health Knowledge and Intelligence Network.
Midland Cancer Network 2012 Clinical Performance Conference.
Premature deaths due to Prostate Cancer: The Role of Diagnosis and Treatment Appathurai Balamurugan MD, MPH S William Ross MD Chris Fisher, BS Jim Files,
Presented at the NAACCR Annual Conference Quebec City June 22, 2010.
Adjuvant Chemotherapy for Non–Small-Cell Lung Cancer in the Elderly: A Population-Based Study in Ontario, Canada JOURNAL OF CLINICAL ONCOLOGY, VOLUME 30.
JHH Prostate Cancer Prostate Cancer Cases Diagnosed 1999 – 2004 Analytic vs. Non-Analytic n=7776 * Analytic - Initially Diagnosed and/or received.
Sex-specific trends in lung cancer incidence and survival : a population study of cases 호흡기 내과 R3 조주희 Thorax 2011;66: Camilla M T Sagerup,
Variation in place of death from cancer: studies in South East England Elizabeth Davies, Peter Madden, Victoria Coupland, Karen Linklater, Henrik Møller.
Prostate cancer and socio-economic deprivation When PCTs are ranked according to their income score using the Indices of Multiple Deprivation (IMD)* there.
UK Hospitalizations due to Stroke in Prostate Cancer Patients
Prognostic significance of tumor subtypes in male breast cancer:
JOHNS HOPKINS HOSPITAL CANCER REGISTRY
(2) - Department of Epidemiology and Population Health, and
JOHNS HOPKINS CANCER REGISTRY 2009
Prognosis of younger patients in non-small cell lung cancer
Male and Female Reproductive Health Concerns
Waleed Alselwi1, Thomas Coventary2, Faisal Azam1
Marcelo Calil Instituto Brasileiro de Controle do Câncer
Dr T P E Wells 13 July 2018 Breast SSG Bath
Published online September 20, 2017 by JAMA Surgery
GOCS GRUPO ONCOLÓGICO COOPERATIVO DEL SUR
Comparing the multiple sources of cancer treatment data
NAACCR/IACR Combined Annual Conference 2019
Presentation transcript:

Prognostic factors for breast cancer survival in affluent and deprived areas Jasmina Stefoski-Mikeljevic

Background Survival from breast cancer is improving due to earlier diagnosis and better treatments Survival breast cancer linked to socio- economic status (SES) SES differences in survival consistent throughout 1980s and 1990s Multi-factorial reasons tumour biology (ER)other tumour characteristics comorbidityadjuvant treatments type of surgery

SES related survival (Yorkshire) 10-year survival for (8% difference at 5 years) 5-year survival for (11% difference)

Study Aim Identify prognostic factors that may be determinants of SES difference in breast cancer survival in Northern and Yorkshire Factors examined: age, stage*, type of adjuvant treatment received (CT, RT, Hormone), type of surgery, GP and hospital delay Methods Retrospective population-based study Female breast cancer patients diagnosed between in the area covered by the Northern and Yorkshire Cancer Registry (n=12,880) Townsend deprivation index * 9% of cases with unknown stage

Age at diagnosis by SES p<

Stage at diagnosis by SES Likelihood of stage I UnadjustedAge adjusted Affluent ( )0.95 ( ) ( )0.89 ( ) Deprived40.79 ( )0.84 ( )

BCS by SES p<

RT by SES p<

Multiple regression analyses (1) Surgery Any Surgery * OR 95% CI OR 95% CI Unadjust. Adjusted * Adjusted for age, stage, GP and hospital delay dep aff dep

Multiple regression analyses (2) Adjuvant therapy RT *Adjusted for age, stage, other adjuvant therapies, type of surgery, GP and hospital delay OR 95% CI OR 95% CI Unadjust. Adjusted* aff dep

Multiple regression analyses (3) GP and hospital delay (>14 days) * Adjusted for age, stage OR95% CI OR 95% CI Unadjust. Adjusted* aff dep

Conclusions Differences between affluent and poor breast cancer patients in -age -stage -type of surgery and RT rates -waiting times for hospital appointment and start of treatment In addition to already identified factors, poorer survival of breast cancer patients from deprived areas is also likely to be explained by a combination of the the above factors ie. older age, more advanced stage, less surgical treatment, less RT, and longer waits for hospital appointment and start of first treatment

K PrakashUniversity of Leeds C Craigs NYCRIS D Forman NYCRIS & Uni of Leeds R Haward NYCRIS & Uni of Leeds Acknowledgements

The Study Population 1, 553 patients diagnosed in Yorkshire between 1995 and cases excluded (treated outside the region and rare types ) Total number of cases: 1,503

Study Population by Age and Stage AgeNo. % < Median age 46 years 25.4% 64+ years old (~40% of all deaths) StageNo.% I II III IV Unknown

Conclusions Stage at diagnosis is related to patients’ age and socio-economic profile Treatment pattern of cervical cancer patients during the study period ( ) was in line with what is now considered good management practice recommended in the national guidelines published in 1999 Survival is influenced by patients’ age and stage, and not by their socio-economic status Patients managed by higher workload gynaecologists have better survival